Candel Therapeutics Ratios (2020-2025) | CADL

Ratios Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
EBT Margin (Quarter)
-15,061.29%-17,148.39%-25,945.16%-129,183.33%-29,551.61%-29,412.90%-29,216.13%-25,403.23%
EBIT Margin (Quarter)
-15,022.58%-17,100.00%-25,900.00%-129,000.00%-28,987.10%-28,235.48%-28,648.39%-26,132.26%
EBITDA Margin (Quarter)
-15,022.58%-55,096.77%-52,135.48%26,600.00%-28,987.10%-28,235.48%-28,648.39%-26,132.26%
Operating Margin (Quarter)
-15,022.58%-17,100.00%-25,900.00%-129,000.00%-28,987.10%-28,235.48%-28,648.39%-26,132.26%
Net Margin (Quarter)
-15,061.29%-17,148.39%-25,945.16%-129,183.33%-29,551.61%-29,412.90%-29,216.13%-25,403.23%
FCF Margin (Quarter)
-24,119.35%-11,445.16%-23,503.23%-95,700.00%-27,335.48%-24,135.48%-28,512.90%-21,590.32%
Efficiency
Assets Average (Quarter)
63.35M92.58M95.38M97.43M89.15M81.35M72.46M62.97M54.38M45.63M36.21M28.85M24.00M64.19M101.39M100.94M99.78M109.40M
Equity Average (Quarter)
-25.53M-35.34M9.91M63.56M63.95M61.92M56.10M49.92M43.68M35.21M26.90M17.88M9.36M-2.00M-12.61M25.54M70.50M82.44M85.17M66.02M
Invested Capital (Quarter)
-27.50M-42.65M63.53M64.70M83.76M80.07M72.13M67.71M40.91M34.42M29.12M21.64M15.75M-0.16M-5.41M76.22M83.85M96.91M84.35M51.92M
Asset Utilization Ratio (Quarter)
0.000.000.000.000.000.00
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-20.12-17.11-14.02-15.82-14.87-13.25-15.33-12.23-15.12-17.98-20.87-26.57-47.36-82.03-11.12
Debt to Equity (Quarter)
0.010.010.010.390.420.510.660.891.613.17-1.06-0.700.160.130.070.050.02
Debt Ratio (Quarter)
0.010.010.010.240.260.300.350.410.500.610.400.500.100.110.060.050.01
Equity Ratio (Quarter)
-1.400.660.720.630.640.610.610.590.520.460.310.19-0.38-0.710.620.780.850.860.41
Times Interest Earned (Quarter)
-20.12-17.11-14.02-15.82-14.87-13.25-15.33-12.23-15.12-17.98-20.87-26.57-47.36-82.03-11.12
Valuation
Enterprise Value (Quarter)
-24.32M-88.39M-82.64M-94.32M-86.78M-77.18M-70.06M-59.26M-51.89M-42.98M-35.41M-25.71M-21.50M-16.56M-102.65M-92.17M-100.69M-86.96M-119.73M
Return Ratios
Return on Sales (Quarter)
-1.51%-1.71%-2.59%-12.92%-2.96%-2.94%-2.92%-2.54%
Return on Capital Employed (Quarter)
-40.90%-29.50%-33.43%-36.60%-41.27%-45.85%-52.61%-66.04%-82.11%-122.08%-161.70%-240.00%-407.05%-125.16%-41.32%-41.99%-45.75%-48.07%
Return on Assets (Quarter)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.02%-0.01%0.00%0.00%0.00%0.00%
Return on Equity (Quarter)
0.01%0.01%-0.02%0.00%0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.02%-0.04%0.18%0.03%-0.01%0.00%0.00%0.00%-0.01%